https://pharmadog.xyz/news/445671 pharmadog en 2026-09-23T18:23:52.000Z FDA panel questions effectiveness of Grail's early-cancer detection test https://pharmadog.xyz/news/445672 pharmadog en 2026-09-23T18:05:52.000Z World's first personalized gene-editing therapy costs $1.65 million per patient, project director says https://pharmadog.xyz/news/445735 pharmadog en 2026-09-23T17:55:00.000Z AI-driven biotech Enveda secures $311 million Series E to advance plant-derived drug candidates https://pharmadog.xyz/news/445291 pharmadog en 2026-09-23T16:21:56.000Z Roche and Ionis report positive Phase 3 interim results for IgA nephropathy drug sefaxersen https://pharmadog.xyz/news/445059 pharmadog en 2026-09-23T15:46:09.000Z Former Changsheng biotech chair sentenced to life in prison over Chinese rabies vaccine scandal https://pharmadog.xyz/news/445060 pharmadog en 2026-09-23T15:21:54.000Z Enveda secures $311 million in third consecutive megaround to advance discovery and weight-maintenance programs https://pharmadog.xyz/news/445083 pharmadog en 2026-09-23T15:15:46.000Z Immunovant halts lupus program after Phase 2b trial fails to meet efficacy endpoints https://pharmadog.xyz/news/445123 pharmadog en 2026-09-23T15:13:51.000Z European pharma CEOs warn of biotech decline as R&D share drops to 31% and call for faster trials and stronger IP protection https://pharmadog.xyz/news/444891 pharmadog en 2026-09-23T14:49:59.000Z Roivant's FcRn drug IMVT-1402 fails Phase 2b lupus trial https://pharmadog.xyz/news/444915 pharmadog en 2026-09-23T14:31:29.000Z AI drug hunter Enveda raises $311M for late-stage obesity, inflammatory disease push https://pharmadog.xyz/news/444747 pharmadog en 2026-09-23T13:50:40.000Z Amgen's Sjögren's drug dazodalibep meets primary endpoint in Phase 3 trial https://pharmadog.xyz/news/444748 pharmadog en 2026-09-23T13:46:25.000Z Roche and Ionis report Phase 3 success for RNA therapy sefaxersen in IgA nephropathy https://pharmadog.xyz/news/444767 pharmadog en 2026-09-23T13:37:36.000Z Flagship Pioneering secures Pentagon contract to develop biological threat countermeasures https://pharmadog.xyz/news/444723 pharmadog en 2026-09-23T13:30:23.000Z Family’s struggle to receive cystic fibrosis medication highlights care gaps https://pharmadog.xyz/news/444768 pharmadog en 2026-09-23T13:29:58.000Z STAT AI Prognosis newsletter tackles AI doomerism and offers guidance for health professionals https://pharmadog.xyz/news/134233 pharmadog en 2026-09-23T13:23:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/444769 pharmadog en 2026-09-23T13:20:31.000Z US to End Personal Medication Import Loophole as New Customs Rule Takes Effect https://pharmadog.xyz/news/444750 pharmadog en 2026-09-23T13:17:51.000Z Novartis signs up to $900 million deal with China's BoomRay for preclinical radioligand therapy https://pharmadog.xyz/news/444724 pharmadog en 2026-09-23T13:00:00.000Z AI startup Basecamp Research secures $140 million Series C funding and outlines six-program AI pipeline https://pharmadog.xyz/news/444579 pharmadog en 2026-09-23T12:43:29.000Z Ionis and Otsuka's RNA therapy Ulefnersen shows functional and survival gains in rare FUS-ALS in Phase 3 trial https://pharmadog.xyz/news/444323 pharmadog en 2026-09-23T11:51:43.000Z US HHS and FDA announce new rules to expand non-animal testing methods as legal battles over youth gender-affirming care continue https://pharmadog.xyz/news/123087 pharmadog en 2026-09-23T11:31:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/444111 pharmadog en 2026-09-23T10:18:53.000Z Roche reports positive interim Phase 3 results for kidney drug, paving way for accelerated approval https://pharmadog.xyz/news/444135 pharmadog en 2026-09-23T10:11:39.000Z Novo outlines $23B revenue goal, cuts 4,000 jobs and expands Wegovy manufacturing amid investor skepticism https://pharmadog.xyz/news/444867 pharmadog en 2026-09-23T09:54:00.000Z Trump's Department of War bets $47M on Flagship biotechs to develop countermeasures https://pharmadog.xyz/news/444866 pharmadog en 2026-09-23T09:47:00.000Z Enveda Biosciences raises $311 million in Series E to accelerate nature-derived drug development https://pharmadog.xyz/news/444698 pharmadog en 2026-09-23T09:00:00.000Z Immunovant halts cutaneous lupus program after phase 2 failure https://pharmadog.xyz/news/444699 pharmadog en 2026-09-23T08:57:00.000Z Boehringer Ingelheim boosts Variant Bio partnership with $250 million for cardiovascular research https://pharmadog.xyz/news/443819 pharmadog en 2026-09-23T08:30:00.000Z Insurers UnitedHealth, CVS, and Kaiser oppose Medicare's contractor ban on remote patient monitoring https://pharmadog.xyz/news/443821 pharmadog en 2026-09-23T08:30:00.000Z Opinion: Mentally ill women need stronger support to become mothers https://pharmadog.xyz/news/443822 pharmadog en 2026-09-23T08:30:00.000Z Quorum Health moves to nonprofit status as its rural hospital chain faces insolvency https://pharmadog.xyz/news/443820 pharmadog en 2026-09-23T08:30:00.000Z FDA shift sparks renewed pharma and VC focus on osteoporosis drug development https://pharmadog.xyz/news/443632 pharmadog en 2026-09-23T07:00:00.000Z Job postings in Pennsylvania’s biopharma sector surge 213% as nine companies ramp up hiring https://pharmadog.xyz/news/443631 pharmadog en 2026-09-23T07:00:00.000Z Pharma companies compete for scarce manufacturing talent as reshoring ramps up https://pharmadog.xyz/news/443019 pharmadog en 2026-09-23T04:18:00.000Z ReCode Therapeutics appoints Heather Clark as CEO to lead cystic fibrosis and primary ciliary dyskinesia programs https://pharmadog.xyz/news/443020 pharmadog en 2026-09-23T04:12:00.000Z China’s $522 bn biotech push fuels US competition and partnership opportunities https://pharmadog.xyz/news/445943 pharmadog en 2026-09-23T04:00:00.000Z FDA issues early alert on React Health VOCSN ventilators over connector fault https://pharmadog.xyz/news/445942 pharmadog en 2026-09-23T04:00:00.000Z FDA issues early alert on Abiomed Impella controller safety issue https://pharmadog.xyz/news/443582 pharmadog en 2026-09-23T03:35:00.000Z Roche reports phase 3 success for sefaxersen in IgA nephropathy, eyes accelerated approval https://pharmadog.xyz/news/441203 pharmadog en 2026-09-22T19:28:42.000Z HHS rolls out new FDA rule to allow non-animal testing methods in drug development https://pharmadog.xyz/news/441011 pharmadog en 2026-09-22T18:47:51.000Z FDA issues third warning letter to Empower Pharmacy over GLP-1 weight-loss treatments https://pharmadog.xyz/news/441223 pharmadog en 2026-09-22T18:31:00.000Z Amgen's Dazodalibep Shows Positive Results in First Phase 3 Trial for Sjögren’s Syndrome https://pharmadog.xyz/news/441012 pharmadog en 2026-09-22T18:12:20.000Z US officials launch probe into falling German drug prices amid EU pharma push for competitiveness https://pharmadog.xyz/news/440843 pharmadog en 2026-09-22T17:49:48.000Z Novo CEO acknowledges need to rebuild investor confidence after muted capital markets day https://pharmadog.xyz/news/440887 pharmadog en 2026-09-22T17:49:03.000Z Former FDA Commissioners Endorse Heidi Overton as Strong Choice to Lead Agency https://pharmadog.xyz/news/440844 pharmadog en 2026-09-22T17:45:50.000Z Vertex reports early kidney drug data, boosting hopes for broad label ahead of next year's pivotal readout https://pharmadog.xyz/news/440611 pharmadog en 2026-09-22T16:23:21.000Z Trump Medicaid pricing plan may give Novo Nordisk unexpected financial boost https://pharmadog.xyz/news/440631 pharmadog en 2026-09-22T16:10:00.000Z Viking Therapeutics reports obesity drug maintains weight loss after dosing switch, shares jump 36% https://pharmadog.xyz/news/440591 pharmadog en 2026-09-22T16:09:53.000Z Compass Therapeutics to file BLA for tovecimig despite FDA call for new trial https://pharmadog.xyz/news/440592 pharmadog en 2026-09-22T16:02:06.000Z Viking Therapeutics’ VK2735 shows 17.7% weight loss in Phase 1 and maintains effect with less frequent dosing https://pharmadog.xyz/news/440463 pharmadog en 2026-09-22T15:42:00.000Z Celldex shares drop as Phase 3 data for barzolvolimab show efficacy but raise anaphylaxis safety concerns https://pharmadog.xyz/news/440399 pharmadog en 2026-09-22T15:31:09.000Z Celldex's barzolvolimab meets Phase 3 goals but safety concerns emerge https://pharmadog.xyz/news/440400 pharmadog en 2026-09-22T15:29:54.000Z Amgen reports positive Phase 3 results for Sjögren's drug; Novartis announces $900M radioligand partnership https://pharmadog.xyz/news/440424 pharmadog en 2026-09-22T15:12:10.000Z Novo aims to increase oral Wegovy manufacturing capacity tenfold by 2030 https://pharmadog.xyz/news/440401 pharmadog en 2026-09-22T15:07:05.000Z Viking touts once-a-month weight loss maintenance data https://pharmadog.xyz/news/440425 pharmadog en 2026-09-22T15:03:41.000Z Lilly presents early data supporting GLP-1/GIP candidate's potential in depression, alcohol use disorder https://pharmadog.xyz/news/440231 pharmadog en 2026-09-22T14:37:01.000Z Nvidia-backed Iambic Therapeutics files for IPO, unveils AI-driven pipeline https://pharmadog.xyz/news/440275 pharmadog en 2026-09-22T14:23:00.000Z Novo Nordisk may secure more favorable terms under Medicare’s Bridge obesity drug program https://pharmadog.xyz/news/440255 pharmadog en 2026-09-22T14:19:06.000Z Four biotech firms file for IPOs as 2026 biotech listing surge continues https://pharmadog.xyz/news/440295 pharmadog en 2026-09-22T14:17:00.000Z Alkermes reports early proof-of-concept for orexin-2 drug in ADHD https://pharmadog.xyz/news/443918 pharmadog en 2026-09-22T13:59:00.000Z GSK pursues China-centric growth after successful Hansoh licensing deals show promise https://pharmadog.xyz/news/440256 pharmadog en 2026-09-22T13:56:39.000Z Novo Nordisk cuts 13,000 jobs to redirect funds toward R&D https://pharmadog.xyz/news/440063 pharmadog en 2026-09-22T13:49:59.000Z Insurers Begin Accelerating AI Adoption After Lagging Behind Providers https://pharmadog.xyz/news/440087 pharmadog en 2026-09-22T13:31:46.000Z Roche’s enicepatide shows dose-dependent blood sugar and weight loss in Phase 2 diabetes trial https://pharmadog.xyz/news/440986 pharmadog en 2026-09-22T13:26:00.000Z Novartis licenses preclinical radioligand from China's BoomRay in up to $900 million deal https://pharmadog.xyz/news/440107 pharmadog en 2026-09-22T13:15:05.000Z STAT Health Tech newsletter highlights Epic's AI mortality model and Omada's upcoming products https://pharmadog.xyz/news/440108 pharmadog en 2026-09-22T13:14:34.000Z Western pharma firms lobby Trump administration to preserve China partnership opportunities https://pharmadog.xyz/news/440088 pharmadog en 2026-09-22T13:10:48.000Z Boehringer Ingelheim to invest up to $1B in AI-driven solid tumor partnership with Envisagenics https://pharmadog.xyz/news/440064 pharmadog en 2026-09-22T13:00:09.000Z Federal AI Initiative Aims to Improve Chronic Heart Failure Care, Pending Doctor and Patient Acceptance https://pharmadog.xyz/news/439663 pharmadog en 2026-09-22T11:54:41.000Z John Gaitanis appointed chair of federal autism committee amid disclosed leucovorin ties https://pharmadog.xyz/news/439683 pharmadog en 2026-09-22T11:00:00.000Z Trump administration’s MFN drug pricing deals may cut projected Medicare savings by up to 80% https://pharmadog.xyz/news/439451 pharmadog en 2026-09-22T10:57:22.000Z Roche presents positive Phase 2 results for enicepatide in overweight and obese type 2 diabetes patients https://pharmadog.xyz/news/440374 pharmadog en 2026-09-22T10:31:00.000Z Celldex reports dual Phase 3 successes for barzolvolimab in refractory chronic spontaneous urticaria https://pharmadog.xyz/news/440206 pharmadog en 2026-09-22T10:24:00.000Z Amgen’s Horizon-acquired drug dazodalibep meets primary endpoint in phase 3 Sjögren’s trial https://pharmadog.xyz/news/440207 pharmadog en 2026-09-22T10:10:00.000Z Vertex reports positive Phase 2b results for inaxaplin in APOL1-mediated kidney disease https://pharmadog.xyz/news/440208 pharmadog en 2026-09-22T10:00:00.000Z Lexeo Therapeutics acquires Mantle Therapeutics for $8.3M to expand Friedreich ataxia pipeline https://pharmadog.xyz/news/440038 pharmadog en 2026-09-22T09:23:00.000Z Otsuka and Ionis report ALS drug ulefnersen meets primary endpoint in phase 3 trial https://pharmadog.xyz/news/440039 pharmadog en 2026-09-22T09:06:00.000Z Siemens Healthineers partners with Novo to raise awareness and testing for fatty liver disease https://pharmadog.xyz/news/439161 pharmadog en 2026-09-22T08:30:00.000Z Global social media bans for teens spark call for rigorous impact research https://pharmadog.xyz/news/439160 pharmadog en 2026-09-22T08:30:00.000Z GOP health policy guru continues to support $1 trillion Medicaid cuts, warning of next target https://pharmadog.xyz/news/439159 pharmadog en 2026-09-22T08:30:00.000Z Ohio governor race pits former public health director against biotech entrepreneur, highlighting Covid response and health policy https://pharmadog.xyz/news/439162 pharmadog en 2026-09-22T08:30:00.000Z Integrative Oncology Proven to Ease Cancer Symptoms, Yet Insurance Still Refuses Coverage https://pharmadog.xyz/news/440380 pharmadog en 2026-09-22T08:19:00.000Z Cordis receives FDA approval for first sirolimus drug-coated balloon for coronary in-stent restenosis https://pharmadog.xyz/news/438359 pharmadog en 2026-09-22T04:45:00.000Z AI becomes core to biopharma R&D, driving efficiency and faster drug development https://pharmadog.xyz/news/443751 pharmadog en 2026-09-22T04:28:00.000Z Anaconda Biomed snares $56M in funding for endovascular tech https://pharmadog.xyz/news/439258 pharmadog en 2026-09-22T04:06:00.000Z Roche’s dual GLP-1/GIP drug enicepatide lowers HbA1c in phase 2 trial, sparking best-in-disease hopes https://pharmadog.xyz/news/439090 pharmadog en 2026-09-22T03:18:00.000Z Iambic Therapeutics eyes IPO as it pushes HER2 inhibitor IAM1363 into early trials https://pharmadog.xyz/news/441845 pharmadog en 2026-09-22T00:00:00.000Z Global regulators must align on new approach methodologies to give sponsors certainty https://pharmadog.xyz/news/440641 pharmadog en 2026-09-22T00:00:00.000Z Consumer groups call on FDA to strengthen generic drug testing and safety reporting under GDUFA IV https://pharmadog.xyz/news/441846 pharmadog en 2026-09-22T00:00:00.000Z Regulators Share Guidance for Effective Sponsor Meetings https://pharmadog.xyz/news/441233 pharmadog en 2026-09-22T00:00:00.000Z Pharma firms ask Trump admin to safeguard China partnerships as EU pushes for quicker trials and higher spending https://pharmadog.xyz/news/437155 pharmadog en 2026-09-21T22:17:21.000Z Congress pushes back on White House plan to place political appointees on NIH grant reviews